














Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference
Published in Health and Fitness on Thursday, May 3rd 2012 at 4:36 GMT by Market Wire

May 03, 2012 07:30 ET
Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference
SYDNEY, AUSTRALIA--(Marketwire - May 3, 2012) - Prima BioMed Ltd (
The presentation will be webcast live and may be accessed by visiting Prima BioMed's website at [ http://www.primabiomed.com.au/investor/presentations.php ]. A replay of the webcast will be available for 10 business days following the presentation.
About Prima BioMed
Prima BioMed is a NASDAQ and ASX and listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology.
Prima's lead product is the CVac™ ovarian cancer therapy treatment. CVac™ has completed two successful clinical trials and is progressing advanced clinical development in the United States, Australia, and Europe.
The Company's broader, long term goal is to develop cancer treatment technologies and programs for global markets.